Straumann Holding AG Other Non-Current Liabilities 2012-2024 | SAUHY

Straumann Holding AG other non-current liabilities from 2012 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Straumann Holding AG other non-current liabilities for the quarter ending December 31, 2024 were $0.654B, a 36.69% decline year-over-year.
  • Straumann Holding AG other non-current liabilities for 2024 were $0.589B, a 21.76% decline from 2023.
  • Straumann Holding AG other non-current liabilities for 2023 were $0.753B, a 48.97% increase from 2022.
  • Straumann Holding AG other non-current liabilities for 2022 were $0.506B, a 279.08% increase from 2021.
Straumann Holding AG Annual Other Non-Current Liabilities
(Millions of US $)
2024 $589
2023 $753
2022 $506
2021 $133
2020 $899
2019 $341
2018 $95
2017 $118
2016 $40
2015 $38
2014 $44
2013 $65
2012 $25
2011 $19
Straumann Holding AG Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-12-31 $654
2023-12-31 $791
2022-12-31 $518
2021-12-31 $201
2021-06-30 $1,033
2020-12-31 $977
2020-06-30 $687
2019-12-31 $410
2018-12-31 $156
2017-12-31 $168
2017-06-30 $150
2016-12-31 $87
2016-06-30 $96
2015-12-31 $84
2014-12-31 $85
2013-12-31 $65
2013-06-30 $47
2012-12-31 $25
2012-06-30 $20
2011-12-31 $19
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.974B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.865B 21.46
Becton Dickinson (BDX) United States $51.847B 12.84
Cardinal Health (CAH) United States $38.059B 19.93
West Pharmaceutical Services (WST) United States $15.920B 33.37
Cooper (COO) United States $14.651B 18.88
Align Technology (ALGN) United States $13.937B 27.67
Henry Schein (HSIC) United States $8.460B 14.51
Merit Medical Systems (MMSI) United States $4.996B 24.15
DENTSPLY SIRONA (XRAY) United States $3.145B 9.39
CONMED (CNMD) United States $1.524B 11.40
STAAR Surgical (STAA) United States $0.855B 0.00
Lifevantage (LFVN) United States $0.168B 17.29
Pro-Dex (PDEX) United States $0.154B 16.88